Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 916 shares at $177.32 ($162K) on 2022-06-27, disclosed to the SEC on 2022-06-28.
Open-market sale of $162k BGNE by Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $177.32 | 458 | $81K | 50.0% |
| 2 | $177.32 | 458 | $81K | 50.0% |
| Total | $177.32 avg | 916 | $162K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |